glp 1 receptor brain GLP-1 agonists show promise in treating substance use disorders JCI - DREADDing proglucagon neurons:

10.1038/s41574-022-00783-3 31 HavranekB.LohR.TorreB.RedfieldR.Halegoua-DemarzioD

Of the employers that said their health plan offerings do not cover GLP-1s for weight loss, a majority said they were not likely to begin covering GLP-1s for weight loss within the next 12 months (and only 1% said they were very likely to do so)

In addition, new drugs such as tirzepatide have come onto the market, expanding the therapeutic options for successful treatment of T2DM and obesity

If your blood pressure consistently improves, your provider can decide whether your medication plan should stay the same or be adjusted

FDA-Approved Medications For anyone researching SkinnyRx, this is the most important distinction to understand upfront